Literature DB >> 10922005

Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP.

P J Lupardus1, R A Wilke, E Aydar, C P Palmer, Y Chen, A E Ruoho, M B Jackson.   

Abstract

Receptor-mediated modulation of ion channels generally involves G-proteins, phosphorylation, or both in combination. The sigma receptor, which modulates voltage-gated K+ channels, is a novel protein with no homology to other receptors known to modulate ion channels. In the present study patch clamp and photolabelling techniques were used to investigate the mechanism by which sigma receptors modulate K+ channels in peptidergic nerve terminals. The sigma receptor photoprobe iodoazidococaine labelled a protein with the same molecular mass (26 kDa) as the sigma receptor protein identified by cloning. The sigma receptor ligands pentazocine and SKF10047 modulated K+ channels, despite intra-terminal perfusion with GTP-free solutions, a G-protein inhibitor (GDPbetaS), a G-protein activator (GTPgammaS) or a non-hydrolysable ATP analogue (AMPPcP). Channels in excised outside-out patches were modulated by ligand, indicating that soluble cytoplasmic factors are not required. In contrast, channels within cell-attached patches were not modulated by ligand outside a patch, indicating that receptors and channels must be in close proximity for functional interactions. Channels expressed in oocytes without receptors were unresponsive to sigma receptor agonists, ruling out inhibition through a direct drug interaction with channels. These experiments indicate that sigma receptor-mediated signal transduction is membrane delimited, and requires neither G-protein activation nor protein phosphorylation. This novel transduction mechanism is mediated by membrane proteins in close proximity, possibly through direct interactions between the receptor and channel. This would allow for more rapid signal transduction than other ion channel modulation mechanisms, which in the present case of neurohypophysial nerve terminals would lead to the enhancement of neuropeptide release.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922005      PMCID: PMC2270035          DOI: 10.1111/j.1469-7793.2000.00527.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  45 in total

1.  Kappa-opioid receptor activation modulates Ca2+ currents and secretion in isolated neuroendocrine nerve terminals.

Authors:  K I Rusin; D R Giovannucci; E L Stuenkel; H C Moises
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

2.  Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.

Authors:  M C Sanguinetti; M E Curran; A Zou; J Shen; P S Spector; D L Atkinson; M T Keating
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

Review 3.  Regulation of potassium channels by protein kinases.

Authors:  E A Jonas; L K Kaczmarek
Journal:  Curr Opin Neurobiol       Date:  1996-06       Impact factor: 6.627

Review 4.  The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis.

Authors:  F F Moebius; J Striessnig; H Glossmann
Journal:  Trends Pharmacol Sci       Date:  1997-03       Impact factor: 14.819

Review 5.  G protein interaction with K+ and Ca2+ channels.

Authors:  T Schneider; P Igelmund; J Hescheler
Journal:  Trends Pharmacol Sci       Date:  1997-01       Impact factor: 14.819

6.  Protein phosphorylation and calcium uptake into rat forebrain synaptosomes: modulation by the sigma ligand, 1,3-ditolylguanidine.

Authors:  P J Brent; L Herd; H Saunders; A T Sim; P R Dunkley
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

7.  K+ channel modulation in rodent neurohypophysial nerve terminals by sigma receptors and not by dopamine receptors.

Authors:  R A Wilke; P J Lupardus; D K Grandy; M Rubinstein; M J Low; M B Jackson
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

8.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site.

Authors:  M Hanner; F F Moebius; A Flandorfer; H G Knaus; J Striessnig; E Kempner; H Glossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

9.  Sigma receptor photolabeling and sigma receptor-mediated modulation of potassium channels in tumor cells.

Authors:  R A Wilke; R P Mehta; P J Lupardus; Y Chen; A E Ruoho; M B Jackson
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

10.  Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1).

Authors:  R Kekuda; P D Prasad; Y J Fei; F H Leibach; V Ganapathy
Journal:  Biochem Biophys Res Commun       Date:  1996-12-13       Impact factor: 3.575

View more
  40 in total

Review 1.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

Review 2.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

3.  Demonstration of a direct interaction between sigma-1 receptors and acid-sensing ion channels.

Authors:  Stewart M Carnally; Molly Johannessen; Robert M Henderson; Meyer B Jackson; J Michael Edwardson
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

Review 4.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

5.  The sigma receptor: evolution of the concept in neuropsychopharmacology.

Authors:  T Hayashi; Tp Su
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

6.  Antagonists show GTP-sensitive high-affinity binding to the sigma-1 receptor.

Authors:  J M Brimson; C A Brown; S T Safrany
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

7.  Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding.

Authors:  Felix J Kim; Ivanka Kovalyshyn; Maxim Burgman; Claire Neilan; Chih-Cheng Chien; Gavril W Pasternak
Journal:  Mol Pharmacol       Date:  2010-01-20       Impact factor: 4.436

8.  The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.

Authors:  Dominique Fontanilla; Molly Johannessen; Abdol R Hajipour; Nicholas V Cozzi; Meyer B Jackson; Arnold E Ruoho
Journal:  Science       Date:  2009-02-13       Impact factor: 47.728

9.  Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems.

Authors:  Molly Johannessen; Subramaniam Ramachandran; Logan Riemer; Andrea Ramos-Serrano; Arnold E Ruoho; Meyer B Jackson
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-11       Impact factor: 4.249

10.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.